Breaking News

British cell and gene therapy accelerator releases annual report

The CGT Catapult has worked on more than 110 projects addressing industry challenges

UK government releases £125 million in grant funding to support innovators

The cash injection will see businesses turn ideas into new products and services on the market

Mile High Labs buys ex-Novartis site in Colorado to produce CBD products

The Broomfield facility comprises 400,000 sqft of pharmaceutical production space

Industrial coatings company chooses ABB Ability to achieve zero downtime

Transcontinental Advanced Coatings has piloted ABB's system on equipment at its Wrexham facility

Teva completes facilities purchase in Pennsylvania

Investment will see the Israeli drug-make set up a Research & Development campus in the US

Boehringer Ingelheim acquires Swiss biotech company AMAL Therapeutics

The German drug-maker plans to combine assets from its cancer immunology portfolio with AMAL’s immunisation platform

Nanonisation: Tiny technology to turn drug failures to success

Finnish biotech Nanoform opens up on the new process that is quickly catching on among drug developers and manufacturers

Colorcon to build starch manufacturing plant in Europe

Pennsylvania-based coating company plans new site near Amsterdam to double production capacity

Bosch sells Packaging Machinery business to private equity firm

Luxemburg-based CVC Capital Partners has purchased the business but the pharma and food units will remain intact

Process optimisation with flow chemistry

WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more ...

Preparing for the paradigm shift in bioprocessing

While upstream titers have improved dramatically over the last decade, downstream processing has remained relatively ...

Purification workflow for isolating cannabinoids from hemp using CPC

Using centrifugal partition chromatography can yield a recovery rate that is greater than the average HPLC method and ...

Kenya bans drug imports with locally manufactured alternatives

Ruling is part of the ‘Big Four Agenda’ to see manufacturing account for 15% of economic output by 2022

Nexus Pharmaceuticals plans $250m sterile injectables facility in the US

Facility in Wisconsin will support the production and supply of injectable drugs in an array of therapeutic areas ...